US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 44.220
  • +0.750+1.73%
Close Dec 20 16:00 ET
  • 44.220
  • 0.0000.00%
Post 20:01 ET
4.08BMarket Cap-6.96P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
42.27%139.49M
35.75%147.03M
8.30%108.83M
19.52%434.25M
23.27%127.39M
8.10%98.05M
21.23%108.31M
25.72%100.5M
3.39%363.33M
23.93%103.35M
Operating revenue
42.27%139.49M
35.75%147.03M
8.30%108.83M
19.52%434.25M
23.27%127.39M
8.10%98.05M
21.23%108.31M
25.72%100.5M
3.39%363.33M
23.93%103.35M
Cost of revenue
91.33%21.02M
114.65%21.28M
43.04%17.53M
59.64%45.21M
126.57%12.05M
27.30%10.99M
19.88%9.91M
100.93%12.26M
76.91%28.32M
51.58%5.32M
Gross profit
36.07%118.47M
27.80%125.75M
3.47%91.3M
16.13%389.04M
17.66%115.34M
6.08%87.07M
21.37%98.4M
19.51%88.24M
-0.12%335.01M
22.72%98.03M
Operating expense
7.88%250.46M
-1.72%242.11M
5.90%256.65M
-2.61%958.25M
-2.57%237.39M
-24.41%232.16M
10.64%246.35M
15.15%242.34M
37.20%983.93M
33.55%243.66M
Selling and administrative expenses
7.25%80.35M
-0.98%80.6M
1.98%78.16M
11.38%309.8M
5.47%76.83M
7.27%74.92M
19.47%81.4M
13.87%76.65M
26.44%278.14M
22.58%72.85M
Research and development costs
8.18%170.11M
-2.09%161.5M
7.72%178.49M
-8.12%648.45M
-6.00%160.56M
-33.73%157.25M
6.74%164.95M
15.75%165.7M
41.97%705.79M
38.85%170.81M
Operating profit
9.04%-131.99M
21.35%-116.36M
-7.30%-165.35M
12.28%-569.21M
16.19%-122.05M
35.53%-145.1M
-4.49%-147.96M
-12.79%-154.11M
-69.99%-648.92M
-41.99%-145.63M
Net non-operating interest income expense
57.73%-4.98M
9.05%-8.56M
24.86%-7.02M
-23.09%-39.32M
9.31%-8.78M
-6.91%-11.78M
-82.63%-9.41M
-53.46%-9.35M
-16.17%-31.94M
-187.63%-9.68M
Non-operating interest income
82.47%10.73M
24.09%7.4M
40.29%8.82M
141.00%26.69M
38.00%8.55M
68.85%5.88M
563.40%5.96M
1,173.28%6.29M
474.38%11.07M
1,308.64%6.2M
Non-operating interest expense
-11.06%15.71M
3.80%15.96M
1.35%15.85M
53.44%66M
9.16%17.33M
21.79%17.67M
154.05%15.38M
137.48%15.64M
46.20%43.02M
317.30%15.87M
Other net income (expense)
277.29%3.76M
-236.81%-5.82M
8,334.62%2.14M
100.29%60K
94.65%3.93M
22.45%-2.12M
84.45%-1.73M
99.71%-26K
52.31%-20.87M
112.24%2.02M
Gain on sale of security
147.78%678K
-1,629.12%-3.99M
1,221.56%3.75M
102.06%397K
2.66%1.89M
12.73%-1.42M
102.56%261K
96.42%-334K
54.12%-19.3M
111.43%1.84M
Other non- operating income (expenses)
540.20%3.08M
8.04%-1.83M
-621.10%-1.61M
78.48%-337K
1,035.00%2.04M
36.74%-699K
-113.87%-1.99M
6.57%308K
7.17%-1.57M
143.90%180K
Income before tax
16.22%-133.21M
17.82%-130.74M
-4.13%-170.23M
13.29%-608.46M
17.22%-126.89M
33.42%-159M
-0.78%-159.1M
-7.72%-163.48M
-54.91%-701.73M
-25.19%-153.28M
Income tax
-53.38%303K
17.21%858K
-8.08%455K
-132.04%-1.83M
-155.13%-3.7M
-89.66%650K
142.38%732K
-11.29%495K
445.59%5.7M
-7,355.00%-1.45M
Net income
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
Net income continuous Operations
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
Minority interest income
Net income attributable to the parent company
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
Basic earnings per share
37.22%-1.4
32.44%-1.52
12.88%-2.03
18.48%-8.25
29.63%-1.52
36.29%-2.23
0.44%-2.25
-6.39%-2.33
-51.04%-10.12
-20.67%-2.16
Diluted earnings per share
37.22%-1.4
32.44%-1.52
12.88%-2.03
18.48%-8.25
29.63%-1.52
36.29%-2.23
0.44%-2.25
-6.39%-2.33
-51.04%-10.12
-20.67%-2.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 42.27%139.49M35.75%147.03M8.30%108.83M19.52%434.25M23.27%127.39M8.10%98.05M21.23%108.31M25.72%100.5M3.39%363.33M23.93%103.35M
Operating revenue 42.27%139.49M35.75%147.03M8.30%108.83M19.52%434.25M23.27%127.39M8.10%98.05M21.23%108.31M25.72%100.5M3.39%363.33M23.93%103.35M
Cost of revenue 91.33%21.02M114.65%21.28M43.04%17.53M59.64%45.21M126.57%12.05M27.30%10.99M19.88%9.91M100.93%12.26M76.91%28.32M51.58%5.32M
Gross profit 36.07%118.47M27.80%125.75M3.47%91.3M16.13%389.04M17.66%115.34M6.08%87.07M21.37%98.4M19.51%88.24M-0.12%335.01M22.72%98.03M
Operating expense 7.88%250.46M-1.72%242.11M5.90%256.65M-2.61%958.25M-2.57%237.39M-24.41%232.16M10.64%246.35M15.15%242.34M37.20%983.93M33.55%243.66M
Selling and administrative expenses 7.25%80.35M-0.98%80.6M1.98%78.16M11.38%309.8M5.47%76.83M7.27%74.92M19.47%81.4M13.87%76.65M26.44%278.14M22.58%72.85M
Research and development costs 8.18%170.11M-2.09%161.5M7.72%178.49M-8.12%648.45M-6.00%160.56M-33.73%157.25M6.74%164.95M15.75%165.7M41.97%705.79M38.85%170.81M
Operating profit 9.04%-131.99M21.35%-116.36M-7.30%-165.35M12.28%-569.21M16.19%-122.05M35.53%-145.1M-4.49%-147.96M-12.79%-154.11M-69.99%-648.92M-41.99%-145.63M
Net non-operating interest income expense 57.73%-4.98M9.05%-8.56M24.86%-7.02M-23.09%-39.32M9.31%-8.78M-6.91%-11.78M-82.63%-9.41M-53.46%-9.35M-16.17%-31.94M-187.63%-9.68M
Non-operating interest income 82.47%10.73M24.09%7.4M40.29%8.82M141.00%26.69M38.00%8.55M68.85%5.88M563.40%5.96M1,173.28%6.29M474.38%11.07M1,308.64%6.2M
Non-operating interest expense -11.06%15.71M3.80%15.96M1.35%15.85M53.44%66M9.16%17.33M21.79%17.67M154.05%15.38M137.48%15.64M46.20%43.02M317.30%15.87M
Other net income (expense) 277.29%3.76M-236.81%-5.82M8,334.62%2.14M100.29%60K94.65%3.93M22.45%-2.12M84.45%-1.73M99.71%-26K52.31%-20.87M112.24%2.02M
Gain on sale of security 147.78%678K-1,629.12%-3.99M1,221.56%3.75M102.06%397K2.66%1.89M12.73%-1.42M102.56%261K96.42%-334K54.12%-19.3M111.43%1.84M
Other non- operating income (expenses) 540.20%3.08M8.04%-1.83M-621.10%-1.61M78.48%-337K1,035.00%2.04M36.74%-699K-113.87%-1.99M6.57%308K7.17%-1.57M143.90%180K
Income before tax 16.22%-133.21M17.82%-130.74M-4.13%-170.23M13.29%-608.46M17.22%-126.89M33.42%-159M-0.78%-159.1M-7.72%-163.48M-54.91%-701.73M-25.19%-153.28M
Income tax -53.38%303K17.21%858K-8.08%455K-132.04%-1.83M-155.13%-3.7M-89.66%650K142.38%732K-11.29%495K445.59%5.7M-7,355.00%-1.45M
Net income 16.37%-133.52M17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M
Net income continuous Operations 16.37%-133.52M17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M
Minority interest income
Net income attributable to the parent company 16.37%-133.52M17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.37%-133.52M17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M
Basic earnings per share 37.22%-1.432.44%-1.5212.88%-2.0318.48%-8.2529.63%-1.5236.29%-2.230.44%-2.25-6.39%-2.33-51.04%-10.12-20.67%-2.16
Diluted earnings per share 37.22%-1.432.44%-1.5212.88%-2.0318.48%-8.2529.63%-1.5236.29%-2.230.44%-2.25-6.39%-2.33-51.04%-10.12-20.67%-2.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List